Key tips for clinicians include: Ask about gallbladder history before starting therapy Monitor for right upper quadrant pain or nausea after meals Educate patients on when to seek medical evaluation For most, the benefits of GLP1 therapy outweigh the risks, but patient awareness is critical for timely diagnosis and care
Patients using both should undergo routine monitoring of lipid panels, hemoglobin A1C, hematocrit, and blood pressure to ensure both medications are contributing to improved metabolic health rather than working at cross-purposes
stomach body
Most patients report initial improvements in clarity and focus within 2 to 4 weeks
355,356,357 Giredestrant, despite not reaching statistical significance for the primary endpoint of investigator-assessed PFS in the acelERA BC phase 2 study, demonstrated comparable efficacy to the physicians choice of endocrine monotherapy in key subgroups and showed a beneficial trend in the ESR1 -mutant population
Stabilized Sulforaphane for clinical use: phytochemical delivery efficiency